Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2022 August;113(4) > Minerva Medica 2022 August;113(4):640-6

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  GERIATRIC CARDIOLOGY IN THE ELDERLY 

Minerva Medica 2022 August;113(4):640-6

DOI: 10.23736/S0026-4806.21.07777-6

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Severe aortic stenosis and transcatheter aortic valve replacement in elderly patients: utility vs. futility

Pierfranco TERROSU 1 , Alessandro BOCCANELLI 1, Giuseppe SABINO 2, Paolo ALBONI 1, Samuele BALDASSERONI 1, Mario BO 1, Giovambattista DESIDERI 1, Niccolò MARCHIONNI 1, Giuseppe PALAZZO 1, Renzo ROZZINI 1, Andrea UNGAR 1, Francesco VETTA 1, Giovanni ZITO 1

1 SICGe - Società Italiana di Cardiologia Geriatrica, Florence, Italy; 2 Unit of Cardiology, SS. Annunziata University Hospital, Sassari, Italy



Recently, transcatheter aortic valve replacement (TAVR) has emerged as established standard treatment for symptomatic severe aortic stenosis, providing an effective, less-invasive alternative to open cardiac surgery for inoperable or high-risk older patients. In order to assess the anticipated benefit of aortic replacement, considerable interest now lies in better identifying factors likely to predict outcome. In the elderly population frailty and medical comorbidities have been shown to significantly predict mortality, functional recovery and quality of life after transcatheter aortic valve replacement. Scientific literature focused on the three items will be discussed. High likelihood of futility is described in patients with severe chronic lung, kidney, liver disease and/or frailty. The addition of frailty components to conventional risk prediction has been shown to result in improved discrimination for death and disability following the procedure and identifies those individuals least likely to derive benefit. Several dedicated risk score have been proposed to provide new insights into predicted “futile” outcome. However, assessment of frailty according to a limited number of variables is not sufficient, while a multi-dimensional geriatric assessment significantly improves risk prediction. A multidisciplinary heart team that includes geriatricians can allow the customization of therapeutic interventions in elderly patients to optimise care and avoid futility.


KEY WORDS: Transcatheter aortic valve replacement; Frailty; Aged

top of page